Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
06/2010
06/03/2010WO2010009210A3 Acetylsalicyclic acid derivatives useful to treat metabolic syndromes
06/03/2010WO2008151303A8 Long wavelength fluorogenic intercellular ion indicators
06/03/2010US20100137599 Process for preparing 1,4-butandiol monitrate
06/03/2010US20100137585 Fused heteroaryl derivatives
06/03/2010US20100137584 Fused heteroaryl derivatives
06/03/2010US20100137350 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal compositon containing them
06/03/2010US20100137299 Spiro-oxindole compounds and their use as therapeutic agents
06/03/2010US20100137298 Biaryl Sulfonamides and Methods for Using Same
06/03/2010US20100137294 Compounds, compositions and methods for controlling invertebrate pests
06/03/2010US20100137291 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/03/2010US20100137283 Inhibitors of the hiv integrase enzyme
06/03/2010CA2742463A1 3-(benzylamin0)-pyrr0lidine derivatives and their use as nk-3 receptor antagonists
06/03/2010CA2741303A1 Substituted pyrazoloquinolines and derivatives thereof
06/02/2010EP2190831A2 Method for the production of 1,3-dioxolane-2-ones and carboxylic acid esters by means of transacylation in basic reaction conditions
06/02/2010EP2190815A1 Pyrrolidine aryl-ether as nk3 receptor antagonists
06/02/2010EP2102207B1 Spiro-piperidine derivatives as via receptor antagonists
06/02/2010EP1644012B1 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the preparation of medicaments
06/02/2010EP1334732B1 Pharmaceutical preparation of n-[2-(1,6,7,8-tetrahydro-2h-indeno[5,4 b]furan-8-yl)ethyl]propionamide coated with a copolyvidone-containing coating free of polyethylene glycol
06/02/2010CN101717402A Pyrazolo N-substituted dehydronorcantharidin imide derivative and synthesis method and application thereof
06/01/2010USRE41366 Total synthesis of galanthamine, analogues and derivatives thereof
06/01/2010US7727998 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
06/01/2010US7727980 Tricyclic androgen receptor modulator compounds and methods
06/01/2010US7727933 used as pesticides and/or pre- or postemergence herbicides
06/01/2010CA2428817C Copolyvidone-containing preparation
05/2010
05/27/2010WO2010060018A1 Azo and diaza derivatives and uses thereof in phototherapy
05/27/2010WO2010058318A1 1-oxa-8-azaspiro [4, 5 ] decane- 8 -carboxamide compounds as faah inhibitors
05/27/2010WO2010036638A3 Compounds for the treatment of inflammatory disorders
05/27/2010US20100130579 Cancer therapy
05/27/2010US20100130513 Benzimidazoles and analogs thereof as antivirals
05/27/2010US20100130498 Agonists of bitter taste receptors and uses thereof
05/27/2010US20100130495 Compounds 563
05/27/2010US20100130487 Spiro-oxindole compounds and their uses as therapeutic agents
05/27/2010US20100130440 Antiviral nucleosides
05/27/2010CA2741839A1 1-oxa-8-azaspiro [4,5] decane-8-carboxamide compounds as faah inhibitors
05/26/2010EP2189461A1 Crystalline irinotecan hydrochloride and methods for the preparation thereof
05/26/2010EP2188295A2 Pyridine derivatives and methods of use thereof
05/26/2010EP2188284A2 Tricyclic heterocyclic compounds as gaba a modulators
05/26/2010CN1986548B Industrial continuous preparing process of N-tert-butoxy carbonyl-5-aza-2-oxa-3-one-dicyclo-[2,2,1] heptane
05/26/2010CN1986547B Industrial preparing process of N-tert-butoxy carbonyl-5-aza-2-oxa-3-one-dicyclo-[2,2,1] heptance in one cauldron
05/26/2010CN1875022B Tocopherol-modified therapeutic drug compounds
05/26/2010CN1642580B Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
05/26/2010CN101712660A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
05/25/2010US7723367 Amino-tetrazoles analogues and methods of use
05/25/2010US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor
05/25/2010US7723357 Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus
05/25/2010US7723351 A four arm-polyethylene glycol-7-ethyl-10-hydroxycamptothecin conjugate, prodrugs of (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; anticarcinogenic agents
05/25/2010US7723349 N-hydroxy-5-methyl-6-{[4-(3-methylphenyl)piperazin-1-yl]carbonyl}-5-azaspiro[2.5]octane-7-carboxamide for example; treating arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions
05/25/2010US7723343 novel triazolopyrimidine derivatives like 7-(2-(4-(2,5-Difluorophenyl)piperazin-1-yl)ethyl)-2-(furan-2-yl)-7H-pyrrolo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine; to treat central nervous system disorders like depression, Parkinson's disease; senile dementia; psychoses etc.
05/25/2010US7723342 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
05/25/2010CA2470476C Pyrrolidine and piperidine derivates as nk1 antagonists
05/25/2010CA2369232C Fused pyrazolyl compounds
05/24/2010CA2698639A1 Azo and diaza derivatives and uses thereof in phototherapy
05/20/2010WO2010056549A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010WO2010055348A1 [4- (1-amino-ethyl) -cyclohexyl] -methyl-amines as antibacterials
05/20/2010WO2010054961A1 Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
05/20/2010WO2010054515A1 Process for the preparation of 4-(1-hydroxy-1-methylethyl)- 2-propyl-imidazole-5-carboxylates
05/20/2010WO2010027567A3 Tricyclic spirocycle derivatives and methods of use thereof
05/20/2010US20100125072 Spiro-oxindole compounds and their uses as therapeutic agents
05/20/2010CA2742520A1 [4- (1-amino-ethyl) -cyclohexyl] -methyl-amines as antibacterials
05/20/2010CA2742297A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010CA2741018A1 Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
05/19/2010EP2186801A2 Intermediates for synthesizing dibenzorhodamine dyes
05/19/2010EP2186516A1 Novel benzazepine derivative
05/19/2010CN101711252A heterocyclic spiro-compounds
05/19/2010CN101085778B Preparation method for etodolac
05/18/2010US7718810 Supports for oligomer synthesis
05/18/2010US7718706 pesticides and/or herbicides for controlling pests in crop protection, in the domestic sector, in the hygiene sector and in the protection of stored products
05/18/2010US7718704 Immunosuppressant compounds and compositions
05/18/2010US7718186 2-alkoxy-6-alkylphenyl-substituted spirocyclic tetramic acid derivatives
05/18/2010CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2355716C Benzisoxazoles and phenones as .alpha.2-antagonists
05/14/2010WO2010054285A2 Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
05/14/2010WO2010054067A1 Gamma secretase modulators
05/14/2010WO2010053998A1 Spiro-condensed indole derivatives as sodium channel inhibitors
05/14/2010WO2010053438A1 Modulators of amyloid beta.
05/14/2010WO2010052466A2 Pharmaceutical aerosol composition
05/14/2010WO2010052450A1 Tiotropium bromide having a low degree of crystallinity
05/14/2010WO2010051664A1 7h-imidazo[1,20-a]pyrano[2,3-c]pyridine derivations and the use thereof
05/14/2010WO2009134616A8 Novel inhibitors of hepatitis c virus replication
05/14/2010WO2009097515A3 [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
05/14/2010CA2742897A1 Modulators of amyloid beta.
05/14/2010CA2742718A1 Pharmaceutical aerosol composition
05/14/2010CA2742602A1 Gamma secretase modulators
05/14/2010CA2742356A1 Tiotropium bromide having a low degree of crystallinity
05/14/2010CA2741990A1 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
05/13/2010US20100120838 Compounds for the treatment of inflammatory disorders
05/13/2010US20100120816 Camptothecin derivatives with antitumor activity
05/13/2010US20100120810 Compounds and methods for modulating rho gtpases
05/13/2010US20100120808 Spirocyclic heterocyclic derivatives and methods of their use
05/13/2010US20100120805 Fused Bicyclic and Tricyclic Pyrimidine Compounds as Tyrosine Kinase Inhibitors
05/13/2010US20100120740 Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
05/12/2010EP1931630B1 N-substituted 3,4-alkylenedioxypyrroles, ester substituted dihydroxypyrroles and methods for synthesis of these pyrroles
05/12/2010CN1642552B 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
05/12/2010CN101707888A Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
05/12/2010CN101704822A Method for preparing galanthamine
05/12/2010CN101704821A Method for preparing stephanine
05/12/2010CN101092419B (1Z, 4Z, 5Z) - 6 N alkyl - 6 - aza -2 - oxo - 3 - oxa - 4 - methoxy - dicyclo [3, 1, 0] hexane and preparation method and use thereof
05/12/2010CN101054377B Total alkaloids extraction of corydalis, its preparation method, medicine composition containing the total alkaloids extraction and application thereof
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 298